Cangsong Liao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cangsong Liao has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Rui Zhang
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
13 shared publicationsJingxuan Zhang
State Key Laboratory of Chemical Biology, Shanghai Institute of Material Medica, Chinese Academy of Sciences, Shanghai, China
7 shared publicationsChunping Tang
State Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China
6 shared publicationsQiaoqiao Li
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
6 shared publicationsYang Ye
State Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China
6 shared publicationsYanqiong Liu
School of Chinese Materia Medica Nanjing University of Chinese Medicine Nanjing 210023 People's Republic of China
6 shared publications
Latest Publications
- 7 October 2026
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 16 (20) , 20287-20296
Enantiocomplementary Total Biosynthesis of Cyclic Imino Acids Enabled by an SN2 Reaction Catalyzed by a Class I Aldolase and a Transaminase
Cyclic noncanonical imino acids are highly valuable in drug design due to their rigid conformational constraints. However, their structural complexity has limited the development of robust synthetic methods. Herein, we report a concise strategy for the enantiocomplementary total synthesis of these compounds. This route is driven by two key biocatalytic steps: a non-natural SN2 reaction catalyzed by a class I pyruvate aldolase, followed by an enantiocomplementary reductive amination catalyzed by amino acid transaminases. We successfully implement this synthesis in E. coli whole-cell catalysts for streamlined production. From simple precursors, we synthesize 42 cyclic imino acids, including the natural product proferrorosamine A, in yields of up to 98% and with enantioselectivity up to >99% ee. This work underscores the potential of leveraging non-natural activities of class I aldolases to create concise enzymatic routes for synthesizing complex chiral heterocycles beyond imino acids.
- 7 October 2026
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 16 (20) , 20287-20296
Enantiocomplementary Total Biosynthesis of Cyclic Imino Acids Enabled by an SN2 Reaction Catalyzed by a Class I Aldolase and a Transaminase
Cyclic noncanonical imino acids are highly valuable in drug design due to their rigid conformational constraints. However, their structural complexity has limited the development of robust synthetic methods. Herein, we report a concise strategy for the enantiocomplementary total synthesis of these compounds. This route is driven by two key biocatalytic steps: a non-natural SN2 reaction catalyzed by a class I pyruvate aldolase, followed by an enantiocomplementary reductive amination catalyzed by amino acid transaminases. We successfully implement this synthesis in E. coli whole-cell catalysts for streamlined production. From simple precursors, we synthesize 42 cyclic imino acids, including the natural product proferrorosamine A, in yields of up to 98% and with enantioselectivity up to >99% ee. This work underscores the potential of leveraging non-natural activities of class I aldolases to create concise enzymatic routes for synthesizing complex chiral heterocycles beyond imino acids.
- 28 August 2026
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 16 (18) , 17995-18004
Efficient and Stereoselective Enzymatic Synthesis of Multisubstituted α , β -Diamino Acid
α,β-Diamino acids are privileged motifs present in numerous bioactive natural products and synthetic molecules, yet their asymmetric synthesis remains challenging and limited in scope. Herein, we repurpose l-threonine aldolases to catalyze a stereoselective intermolecular Mannich-type reaction, enabling the direct and scalable synthesis of densely functionalized α,β-diamino acids. By exploiting enzyme sequence diversity, we accessed more than 50 derivatives from simple precursors with high efficiency (up to 97% yield) and selectivity (up to >99% d.r. and >99% e.r.). The reaction achieves total turnover numbers of up to 18,000 and titers reaching 77.4 g L–1, representing the highest reported productivity for this class of biocatalytic transformation and meeting key benchmarks for industrial application. Mechanistic investigations suggest that the deprotonation of glycine contributes to the rate-determining step of the highly efficient catalytic cycle. Selected derivatives were shown to effectively suppress osteoclastogenesis, identifying a chemotype with potential for osteoporosis intervention.
- 28 August 2026
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 16 (18) , 17995-18004
Efficient and Stereoselective Enzymatic Synthesis of Multisubstituted α , β -Diamino Acid
α,β-Diamino acids are privileged motifs present in numerous bioactive natural products and synthetic molecules, yet their asymmetric synthesis remains challenging and limited in scope. Herein, we repurpose l-threonine aldolases to catalyze a stereoselective intermolecular Mannich-type reaction, enabling the direct and scalable synthesis of densely functionalized α,β-diamino acids. By exploiting enzyme sequence diversity, we accessed more than 50 derivatives from simple precursors with high efficiency (up to 97% yield) and selectivity (up to >99% d.r. and >99% e.r.). The reaction achieves total turnover numbers of up to 18,000 and titers reaching 77.4 g L–1, representing the highest reported productivity for this class of biocatalytic transformation and meeting key benchmarks for industrial application. Mechanistic investigations suggest that the deprotonation of glycine contributes to the rate-determining step of the highly efficient catalytic cycle. Selected derivatives were shown to effectively suppress osteoclastogenesis, identifying a chemotype with potential for osteoporosis intervention.
- 19 August 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (34) , 25042-25051
Feature-Based Analysis of MS2 Data Reveals a Skeleton-Level Chemical Space and Enables Discovery of Sesquiterpenes with Unprecedented Skeletons
Natural products bearing novel skeletons expand accessible chemical space and may inspire future biological discovery, yet their identification still relies largely on chance. This limitation stems largely from prevailing strategies for representing and interpreting MS2 data and not simply from spectral quality or algorithmic performance. Current workflows treat MS2 spectra as pairwise comparable entities, with structural relationships inferred from similarity, favoring analogues of known scaffolds while obscuring global structural organization. Here, we propose a feature-structured analytical paradigm that treats MS2 data as an integrated signal system shaped by molecular skeletons. By reorganizing spectra into fragment-feature representations and applying non-negative matrix factorization, structural information becomes directly observable at the data set level, revealing a skeleton-level chemical space (SLECS) in which compounds organize according to underlying skeletal features rather than pairwise similarity. Evaluation across diverse data sets shows that the SLECS-based framework resolves skeleton-level organization beyond conventional similarity-based approaches and enables systematic identification of structurally distinct regions. Application to Pilea cavaleriei led to the targeted isolation of seven sesquiterpenes (1–7), including compounds 1 and 2, featuring an unprecedented bicyclo[6.3.1] skeleton, thereby enabling targeted discovery of novel skeletons and expanding the pool of unexplored scaffolds for future biological evaluation. This work establishes a new representation paradigm for MS2 data analysis that complements similarity-based approaches and offers a scalable strategy for structure-oriented exploration of chemical space and the discovery of novel natural product scaffolds.
- 19 August 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (34) , 25042-25051
Feature-Based Analysis of MS2 Data Reveals a Skeleton-Level Chemical Space and Enables Discovery of Sesquiterpenes with Unprecedented Skeletons
Natural products bearing novel skeletons expand accessible chemical space and may inspire future biological discovery, yet their identification still relies largely on chance. This limitation stems largely from prevailing strategies for representing and interpreting MS2 data and not simply from spectral quality or algorithmic performance. Current workflows treat MS2 spectra as pairwise comparable entities, with structural relationships inferred from similarity, favoring analogues of known scaffolds while obscuring global structural organization. Here, we propose a feature-structured analytical paradigm that treats MS2 data as an integrated signal system shaped by molecular skeletons. By reorganizing spectra into fragment-feature representations and applying non-negative matrix factorization, structural information becomes directly observable at the data set level, revealing a skeleton-level chemical space (SLECS) in which compounds organize according to underlying skeletal features rather than pairwise similarity. Evaluation across diverse data sets shows that the SLECS-based framework resolves skeleton-level organization beyond conventional similarity-based approaches and enables systematic identification of structurally distinct regions. Application to Pilea cavaleriei led to the targeted isolation of seven sesquiterpenes (1–7), including compounds 1 and 2, featuring an unprecedented bicyclo[6.3.1] skeleton, thereby enabling targeted discovery of novel skeletons and expanding the pool of unexplored scaffolds for future biological evaluation. This work establishes a new representation paradigm for MS2 data analysis that complements similarity-based approaches and offers a scalable strategy for structure-oriented exploration of chemical space and the discovery of novel natural product scaffolds.
- Open Access
- 26 January 2026
- Published by Wiley in ChemistryEurope
- Vol. 4 (1)
Mannich Reaction With Pyridoxal 5′‐Phosphate Dependent Decarboxylative Aldolase for Synthesis of Noncanonical α ‐Amino Acids
Functionalized benzosultam and sulfonamide derivatives represent privileged pharmacophores in medicinal chemistry. However, noncanonical amino acids (ncAAs) featuring benzosultam side chains remain underexplored for peptide therapeutics, despite significant advances in peptide drug development. Herein, we report the promiscuous activity of the PLP‐dependent decarboxylative aldolase UstD in catalyzing β ‐Mannich reactions. An engineered variant, UstD2.0 S60A , was developed and applied to synthesize 23 enantioenriched ncAAs, achieving yields up to 96%, a total turnover number (TTN) of 7500, and excellent stereoselectivity (>95:5 dr, >99:1 er). The reaction is scalable to gram quantities for preparative applications. This study facilitates the future use of benzosultam‐containing ncAAs in peptide chemistry and highlights the opportunity of engineering aldolases for non‐natural Mannich reaction to access chiral amine products.
- 26 January 2026
- Published by Wiley in ChemistryEurope
- Vol. 4 (1)
Open AccessMannich Reaction With Pyridoxal 5′‐Phosphate Dependent Decarboxylative Aldolase for Synthesis of Noncanonical α ‐Amino Acids
Functionalized benzosultam and sulfonamide derivatives represent privileged pharmacophores in medicinal chemistry. However, noncanonical amino acids (ncAAs) featuring benzosultam side chains remain underexplored for peptide therapeutics, despite significant advances in peptide drug development. Herein, we report the promiscuous activity of the PLP‐dependent decarboxylative aldolase UstD in catalyzing β ‐Mannich reactions. An engineered variant, UstD2.0 S60A , was developed and applied to synthesize 23 enantioenriched ncAAs, achieving yields up to 96%, a total turnover number (TTN) of 7500, and excellent stereoselectivity (>95:5 dr, >99:1 er). The reaction is scalable to gram quantities for preparative applications. This study facilitates the future use of benzosultam‐containing ncAAs in peptide chemistry and highlights the opportunity of engineering aldolases for non‐natural Mannich reaction to access chiral amine products.
- Open Access
- 20 November 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (48) , 44396-44405
Biocatalytic- and Chemoproteomic-Guided Discovery of a PHGDH Inhibitor from Chemoenzymatic-Promoted DNA-Encoded Libraries Selection Platform
DNA-encoded libraries (DELs) have emerged as an effective and efficient selection strategy for lead compound discovery in academia and industry over the past few decades. Despite recent advancements in this field, DEL remains limited by sensitive DNA-based constructs, particularly with low selection success rates resulting from the random selection of targets. Here, we describe a chemoenzymatic on-DNA reaction for DEL syntheses and develop a chemoproteomic-guided DEL selection platform. This platform, termed FF tags-biocatDEL, integrates DEL technology, chemoenzymatic synthesis, and fully functionalized (FF) chemical tags to match DELs with selection targets, even with limited information about ligandable hotspots. Using two diazirine-based FF indole probes, we comprehensively surveyed binding partners in cells and identified phosphoglycerate dehydrogenase (PHGDH) as a potential target for DEL selection. DEL01 and DEL02 were designed, synthesized, and selected against PHGDH, leading to the identification of a novel enzyme-active compound with an IC50 value of 2.5 μM. Our strategy, utilizing FF tags-biocatDEL, establishes a generalizable workflow for rapid target hunting and ligand discovery. It provides an effective method for precisely matching DELs with potential targets, demonstrating its significant potential as a complementary approach to drug discovery based on DELs.
- 20 November 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (48) , 44396-44405
Open AccessBiocatalytic- and Chemoproteomic-Guided Discovery of a PHGDH Inhibitor from Chemoenzymatic-Promoted DNA-Encoded Libraries Selection Platform
DNA-encoded libraries (DELs) have emerged as an effective and efficient selection strategy for lead compound discovery in academia and industry over the past few decades. Despite recent advancements in this field, DEL remains limited by sensitive DNA-based constructs, particularly with low selection success rates resulting from the random selection of targets. Here, we describe a chemoenzymatic on-DNA reaction for DEL syntheses and develop a chemoproteomic-guided DEL selection platform. This platform, termed FF tags-biocatDEL, integrates DEL technology, chemoenzymatic synthesis, and fully functionalized (FF) chemical tags to match DELs with selection targets, even with limited information about ligandable hotspots. Using two diazirine-based FF indole probes, we comprehensively surveyed binding partners in cells and identified phosphoglycerate dehydrogenase (PHGDH) as a potential target for DEL selection. DEL01 and DEL02 were designed, synthesized, and selected against PHGDH, leading to the identification of a novel enzyme-active compound with an IC50 value of 2.5 μM. Our strategy, utilizing FF tags-biocatDEL, establishes a generalizable workflow for rapid target hunting and ligand discovery. It provides an effective method for precisely matching DELs with potential targets, demonstrating its significant potential as a complementary approach to drug discovery based on DELs.
- 9 November 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
Stereoselective De Novo Construction of Cyclopropane by a Multifunctional Class I Aldolase
Cyclopropane is a widely distributed structural unit in natural products and pharmaceuticals. Current strategies in both organic and enzymatic synthesis of cyclopropane scaffolds mainly rely on alkene-based transformations, and de novo construction of all three carbon-carbon bonds of cyclopropane using a single catalyst has not been documented to date. Here, we report that class I pyruvate aldolase NahE can be engineered to catalyze this challenging transformation. NahE facilitates a cascade involving sequential aldol reaction, dehydration, Michael addition, and intramolecular SN2-like substitution, forging all three C-C bonds and establishing three stereocenters in a single catalytic cycle. Three engineered NahE variants synthesize 30 diverse aromatic and aliphatic cyclopropanes in up to 84% isolated yield with excellent stereoselectivity (>20:1 dr, >99% ee).
- 9 November 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
Stereoselective De Novo Construction of Cyclopropane by a Multifunctional Class I Aldolase
Cyclopropane is a widely distributed structural unit in natural products and pharmaceuticals. Current strategies in both organic and enzymatic synthesis of cyclopropane scaffolds mainly rely on alkene-based transformations, and de novo construction of all three carbon-carbon bonds of cyclopropane using a single catalyst has not been documented to date. Here, we report that class I pyruvate aldolase NahE can be engineered to catalyze this challenging transformation. NahE facilitates a cascade involving sequential aldol reaction, dehydration, Michael addition, and intramolecular SN2-like substitution, forging all three C-C bonds and establishing three stereocenters in a single catalytic cycle. Three engineered NahE variants synthesize 30 diverse aromatic and aliphatic cyclopropanes in up to 84% isolated yield with excellent stereoselectivity (>20:1 dr, >99% ee).
- Open Access
- 29 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
A robust platform streamlining aromatic noncanonical amino acid biosynthesis and genetic code expansion in Escherichia coli
Genetic code expansion (GCE) has significantly enhanced the diversity of proteins in the biological world, leading to a wide range of applications. Despite the advances in GCE, the cost of noncanonical amino acids (ncAAs) remains one of the major obstacles for large-scale production. In situ biosynthesis of ncAAs from commercial precursors offers a promising solution to this challenge, yet only a few biosynthetic pathways have been reported. Here, we present a platform that couples the biosynthesis of aromatic ncAAs with genetic code expansion in E. coli, enabling the production of proteins and peptides containing ncAAs. Forty ncAAs are synthesized from aryl aldehydes by the biosynthetic pathway, while nineteen ncAAs are incorporated into superfolder GFP using three orthogonal translation systems. The platform’s versatility is demonstrated by the production of macrocyclic peptides and antibody fragments. We envision that the platform will facilitate the production of peptides, enzymes, and antibody fragments containing ncAAs.
- 29 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Open AccessA robust platform streamlining aromatic noncanonical amino acid biosynthesis and genetic code expansion in Escherichia coli
Genetic code expansion (GCE) has significantly enhanced the diversity of proteins in the biological world, leading to a wide range of applications. Despite the advances in GCE, the cost of noncanonical amino acids (ncAAs) remains one of the major obstacles for large-scale production. In situ biosynthesis of ncAAs from commercial precursors offers a promising solution to this challenge, yet only a few biosynthetic pathways have been reported. Here, we present a platform that couples the biosynthesis of aromatic ncAAs with genetic code expansion in E. coli, enabling the production of proteins and peptides containing ncAAs. Forty ncAAs are synthesized from aryl aldehydes by the biosynthetic pathway, while nineteen ncAAs are incorporated into superfolder GFP using three orthogonal translation systems. The platform’s versatility is demonstrated by the production of macrocyclic peptides and antibody fragments. We envision that the platform will facilitate the production of peptides, enzymes, and antibody fragments containing ncAAs.
- 27 August 2025
- Published by Wiley in ChemCatChem
- Vol. 17 (20)
Asymmetric Radical Alkylation Enabled by Synergistic Photoredox Enamine Biocatalysis
Class I aldolases, a unique link among biochemistry, organic chemistry, and computational chemistry are powerful C─C bond‐forming enzymes in synthetic chemistry and industry because of their unparalleled selectivity, extensive substrate scope and scalability. However, the types of reactions catalyzed by class I aldolases are restricted and radical reactions have yet to be accomplished. Here, we demonstrate a proof‐of‐concept study in which a synergistic photoredox biocatalysis strategy can be applied to realize new catalytic functions of enamine‐dependent aldolases. This new reactivity enables asymmetric alkylation of a prochiral radical under exclusive stereocontrol, a challenging task for amine catalysts. Both enantiomeric products were obtained in a stereoconvergent fashion from wild‐type and engineered aldolases. This synergistic photoredox biocatalysis strategy has resulted in a new‐to‐nature enzymatic reaction and led to an asymmetric transformation that is not feasible for organocatalysis. We envision that this discovery will motivate the development of enzymatic enamine and iminium catalysis for valuable asymmetric radical transformations, complementing the prevailing organocatalysts.
- 27 August 2025
- Published by Wiley in ChemCatChem
- Vol. 17 (20)
Asymmetric Radical Alkylation Enabled by Synergistic Photoredox Enamine Biocatalysis
Class I aldolases, a unique link among biochemistry, organic chemistry, and computational chemistry are powerful C─C bond‐forming enzymes in synthetic chemistry and industry because of their unparalleled selectivity, extensive substrate scope and scalability. However, the types of reactions catalyzed by class I aldolases are restricted and radical reactions have yet to be accomplished. Here, we demonstrate a proof‐of‐concept study in which a synergistic photoredox biocatalysis strategy can be applied to realize new catalytic functions of enamine‐dependent aldolases. This new reactivity enables asymmetric alkylation of a prochiral radical under exclusive stereocontrol, a challenging task for amine catalysts. Both enantiomeric products were obtained in a stereoconvergent fashion from wild‐type and engineered aldolases. This synergistic photoredox biocatalysis strategy has resulted in a new‐to‐nature enzymatic reaction and led to an asymmetric transformation that is not feasible for organocatalysis. We envision that this discovery will motivate the development of enzymatic enamine and iminium catalysis for valuable asymmetric radical transformations, complementing the prevailing organocatalysts.
- 13 August 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (34) , 30863-30872
Bimolecular Nucleophilic Substitution (SN2) Reaction Catalyzed by l-Threonine Aldolase
The bimolecular nucleophilic substitution (SN2) and aldol reactions are cornerstone transformations in organic and biochemical synthesis, yet they operate through fundamentally distinct mechanisms, substrates, and product frameworks. Nature has evolved dedicated enzyme families to catalyze these reactions separately, namely, aldolases for aldol condensations and methyltransferases or similar enzymes for SN2 pathways. Aldolases have not been reported to catalyze SN2 reactions. We herein report the unprecedented repurposing of l-threonine aldolase to catalyze an SN2 reaction. This new activity enables direct asymmetric alkylation of the sp3-hybridized Cα-H bond in glycine using readily accessible α-halide carbonyl compounds. Mechanistic and computational analyses elucidate how the active site of the enzyme precisely aligns substrates into a geometry that facilitates the SN2 transition state. The developed biocatalytic platform provides efficient access to diverse enantiomerically enriched α-amino acids (29 examples), achieving yields up to 95% and exceptional stereocontrol (e.r. > 99:1). This discovery not only expands the catalytic repertoire of aldolases but also underscores the potential for repurposing aldolases to unlock non-native reactivities in sustainable synthesis.
- 13 August 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (34) , 30863-30872
Bimolecular Nucleophilic Substitution (SN2) Reaction Catalyzed by l-Threonine Aldolase
The bimolecular nucleophilic substitution (SN2) and aldol reactions are cornerstone transformations in organic and biochemical synthesis, yet they operate through fundamentally distinct mechanisms, substrates, and product frameworks. Nature has evolved dedicated enzyme families to catalyze these reactions separately, namely, aldolases for aldol condensations and methyltransferases or similar enzymes for SN2 pathways. Aldolases have not been reported to catalyze SN2 reactions. We herein report the unprecedented repurposing of l-threonine aldolase to catalyze an SN2 reaction. This new activity enables direct asymmetric alkylation of the sp3-hybridized Cα-H bond in glycine using readily accessible α-halide carbonyl compounds. Mechanistic and computational analyses elucidate how the active site of the enzyme precisely aligns substrates into a geometry that facilitates the SN2 transition state. The developed biocatalytic platform provides efficient access to diverse enantiomerically enriched α-amino acids (29 examples), achieving yields up to 95% and exceptional stereocontrol (e.r. > 99:1). This discovery not only expands the catalytic repertoire of aldolases but also underscores the potential for repurposing aldolases to unlock non-native reactivities in sustainable synthesis.
- Open Access
- 5 August 2025
- Published by American Chemical Society (ACS) in ChemRxiv
FF tags-SynbioDEL: Biosynthetic and Proteome Profiling-Guided Discovery of PHGDH Inhibitor from Reversible DNA-Encoded Libraries Selection Platform
DNA-encoded libraries (DELs) have emerged as an effective and efficient selection strategy for lead compound discovery in academia and industry over the past decades. Despite recent advancements in this field, DEL is still limited by sensitive DNA-based constructs, especially low selection success rates from random selection of targets. Here, we describe a biosynthesis on-DNA reaction for DEL syntheses and develop a proteome profiling-guided reversible DEL selection platform. This platform, termed FF tags-SynbioDEL, integrates DEL technology, biocatalysis, and fully-functionalized (FF) chemical tags to match DELs with selection targets, even with limited information on ligandable hotspots. Using a diazirine-based FF indole probe, we comprehensively surveyed binding partners in live cells and identified phosphoglycerate dehydrogenase (PHGDH) as a potential target for DEL selection. DEL01 and DEL02 were designed, synthesized, and selected against PHGDH, leading to the identification of a novel enzyme-active compound with an IC50 value of 2.4 μM. Our strategy, utilizing FF tags-SynbioDEL, establishes a generalizable workflow for rapid target hunting, ligand discovery, and optimization. This approach provides a transformative method for matching DELs with potential targets, demonstrating its significant potential in drug discovery.
- 5 August 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessFF tags-SynbioDEL: Biosynthetic and Proteome Profiling-Guided Discovery of PHGDH Inhibitor from Reversible DNA-Encoded Libraries Selection Platform
DNA-encoded libraries (DELs) have emerged as an effective and efficient selection strategy for lead compound discovery in academia and industry over the past decades. Despite recent advancements in this field, DEL is still limited by sensitive DNA-based constructs, especially low selection success rates from random selection of targets. Here, we describe a biosynthesis on-DNA reaction for DEL syntheses and develop a proteome profiling-guided reversible DEL selection platform. This platform, termed FF tags-SynbioDEL, integrates DEL technology, biocatalysis, and fully-functionalized (FF) chemical tags to match DELs with selection targets, even with limited information on ligandable hotspots. Using a diazirine-based FF indole probe, we comprehensively surveyed binding partners in live cells and identified phosphoglycerate dehydrogenase (PHGDH) as a potential target for DEL selection. DEL01 and DEL02 were designed, synthesized, and selected against PHGDH, leading to the identification of a novel enzyme-active compound with an IC50 value of 2.4 μM. Our strategy, utilizing FF tags-SynbioDEL, establishes a generalizable workflow for rapid target hunting, ligand discovery, and optimization. This approach provides a transformative method for matching DELs with potential targets, demonstrating its significant potential in drug discovery.